| Protocol: | MTS1 - Low-Dose Atropine for Prevention of Myopia |
| Status: | Closed |
| Start Date: | 06/01/2018 |
| End Date: | 09/12/2022 |
| Clinical Trial ID: | NCT03334253 |
| Public Dataset: |
Download
|
MTS1 - Low-Dose Atropine for Prevention of Myopia
Protocol
The objectives for this randomized trial are:
- To determine the efficacy of daily low-dose atropine (0.01%) for slowing myopia progression over a two-year treatment period in children aged 5 to less than 13 years with myopia -1.00 to -6.00D at the time of enrollment (Primary Outcome On-Treatment).
- To determine the efficacy of atropine treatment on myopia progression 6 months following cessation of low-dose atropine treatment (Secondary Outcome Off-Treatment).
Back